Falkman L, Sundin A, Skogseid B, Botling J, Bernardo Y, Wallin G, Zhang L, Welin S, Lase I, Mollazadegan K, Crona J. Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors. ujms [Internet]. 2024Apr.9 [cited 2024May21];129(S1):e10660. Available from: https://ujms.net/index.php/ujms/article/view/10660